Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytosorbents Corp CTSO

Healthcare Medical Devices
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive... see more

Recent & Breaking News (NDAQ:CTSO)

CytoSorbents Establishes Swiss Subsidiary

PR Newswire May 6, 2016

CytoSorbents to Report Q1 2016 Operating and Financial Results

PR Newswire May 2, 2016

CytoSorbents To Present At The 15th Annual Needham Healthcare Conference

PR Newswire April 6, 2016

CytoSorbents Awarded $150,000 Phase I SBIR Contract for Fungal Mycotoxin Removal

PR Newswire March 25, 2016

Cytosorb Study: PAMPs and DAMPs Removed

PR Newswire March 17, 2016

CytoSorbents Reports on Successful 3rd International CytoSorb® Users Meeting

PR Newswire March 16, 2016

CytoSorbents to Host 3rd International CytoSorb® Users Meeting and ISICEM 2016 Symposium

PR Newswire March 14, 2016

CytoSorbents Reports Record Quarterly and Full-Year 2015 Revenue

PR Newswire March 9, 2016

CytoSorbents to Report Fiscal 2015 Operating and Financial Results

PR Newswire March 2, 2016

Data Presented on First CytoSorb® Investigator-Initiated Septic Shock Study

PR Newswire February 26, 2016

CytoSorbents to Exhibit at the 45th Society of Critical Care Medicine Congress

PR Newswire February 18, 2016

CytoSorbents Announces 26th Symposium for Intensive Medicine and Intensive Care Agenda in Bremen, Germany

Press Releases February 16, 2016

CytoSorbents to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

PR Newswire February 4, 2016

CytoSorbents Receives $325,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

PR Newswire February 1, 2016

CytoSorbents to Present at the 18th Annual BIO CEO & Investor Conference

PR Newswire January 28, 2016

CytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical Affairs

PR Newswire January 21, 2016

CytoSorbents 2016 - Driving Toward the Inflection Point

PR Newswire January 11, 2016

CytoSorbents To Present at Biotech Showcase 2016

PR Newswire January 4, 2016

CytoSorbents Corporation (Nasdaq:CTSO) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire December 22, 2015

CytoSorbents Issues EAP Update

PR Newswire December 21, 2015